Moreover, studies have found that in the mammary tumor microenvironment (TME), breast cancer cells, via secretion of tumor-derived cytokines, reprogram adjacent adipocytes to increase secretion of ATX, which further drive tumor growth, metastasis, and therapy resistance [17,18,19,20]. The gene discussed is ENPP2; the disease is neoplasm.